Announcements Trials
Browse Landscape

Status

Temporarily not available 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 10Expanded_access 1

Sponsor

Cancer Type

Sarcoma 1Gynecologic 1

Conditions

Uterine Neoplasms 1Uterine Cervical Neoplasms 1Sarcoma, Ewing 1Ovarian Neoplasms 1

Interventions

nilotinib 5dabrafenib 4Nivolumab 4Afatinib 4trametinib 3regorafenib 3midostaurin 3elotuzumab 3TIC10 compound 3Sunitinib 3Prednisone 3Capecitabine 3Abiraterone Acetate 33-Iodobenzylguanidine 3venetoclax 2tucatinib 2tempol 2tazemetostat 2talquetamab 2talimogene laherparepvec 2ruxolitinib 2pomalidomide 2olaparib 2niraparib 2leronlimab 2lenvatinib 2ibrutinib 2gilteritinib 2ceritinib 2brexucabtagene autoleucel 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Expanded_access × FANG vaccine × Clear all
NCT03842865 2025-06-05

Expanded Access of Vigil in Solid Tumors

Gradalis, Inc.

Temporarily not available
GynecologicSarcoma

Uterine Cervical Neoplasms, Ovarian Neoplasms, Sarcoma, Ewing, Uterine Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡